Lupin seeds US spinout with cash, clinical-stage cancer assets
Lupin seeds US spinout with cash, clinical-stage cancer assets.
Lupin
NSE: LUPIN / BSE: 500257 ~$8B MCAP
Lupin is a biopharma company.
Company Info
Recent News
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets Global pharmaceutical leader Lupin Limited (Lupin) (B
Lupin Receives Tentative Approval from U.S. FDA for Enzalutamide Tablets Global pharmaceutical leader Lupin Limited (Lupin) (B
Leadership Team
Careers & Job Openings